img

Global Nasal Spray Influenza Vaccine Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Nasal Spray Influenza Vaccine Market Research Report 2024

Nasal Spray Vaccine refers to a vaccine injected through the nose, which is mostly used for influenza.
According to Mr Accuracy reports new survey, global Nasal Spray Influenza Vaccine market is projected to reach US$ 802.9 million in 2029, increasing from US$ 523 million in 2022, with the CAGR of 6.0% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Nasal Spray Influenza Vaccine market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Nasal Spray Influenza Vaccine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


AstraZeneca
Cipla
BCHT
Segment by Type
Inactive
Live

Segment by Application


Child
Adult

Consumption by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Nasal Spray Influenza Vaccine report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source

Table of Content

1 Nasal Spray Influenza Vaccine Market Overview
1.1 Product Overview and Scope of Nasal Spray Influenza Vaccine
1.2 Nasal Spray Influenza Vaccine Segment by Type
1.2.1 Global Nasal Spray Influenza Vaccine Market Value Comparison by Type (2024-2034)
1.2.2 Inactive
1.2.3 Live
1.3 Nasal Spray Influenza Vaccine Segment by Application
1.3.1 Global Nasal Spray Influenza Vaccine Market Value by Application: (2024-2034)
1.3.2 Child
1.3.3 Adult
1.4 Global Nasal Spray Influenza Vaccine Market Size Estimates and Forecasts
1.4.1 Global Nasal Spray Influenza Vaccine Revenue 2018-2029
1.4.2 Global Nasal Spray Influenza Vaccine Sales 2018-2029
1.4.3 Global Nasal Spray Influenza Vaccine Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Nasal Spray Influenza Vaccine Market Competition by Manufacturers
2.1 Global Nasal Spray Influenza Vaccine Sales Market Share by Manufacturers (2018-2024)
2.2 Global Nasal Spray Influenza Vaccine Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Nasal Spray Influenza Vaccine Average Price by Manufacturers (2018-2024)
2.4 Global Nasal Spray Influenza Vaccine Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Nasal Spray Influenza Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Nasal Spray Influenza Vaccine, Product Type & Application
2.7 Nasal Spray Influenza Vaccine Market Competitive Situation and Trends
2.7.1 Nasal Spray Influenza Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Nasal Spray Influenza Vaccine Players Market Share by Revenue
2.7.3 Global Nasal Spray Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Nasal Spray Influenza Vaccine Retrospective Market Scenario by Region
3.1 Global Nasal Spray Influenza Vaccine Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Nasal Spray Influenza Vaccine Global Nasal Spray Influenza Vaccine Sales by Region: 2018-2029
3.2.1 Global Nasal Spray Influenza Vaccine Sales by Region: 2018-2024
3.2.2 Global Nasal Spray Influenza Vaccine Sales by Region: 2024-2029
3.3 Global Nasal Spray Influenza Vaccine Global Nasal Spray Influenza Vaccine Revenue by Region: 2018-2029
3.3.1 Global Nasal Spray Influenza Vaccine Revenue by Region: 2018-2024
3.3.2 Global Nasal Spray Influenza Vaccine Revenue by Region: 2024-2029
3.4 North America Nasal Spray Influenza Vaccine Market Facts & Figures by Country
3.4.1 North America Nasal Spray Influenza Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Nasal Spray Influenza Vaccine Sales by Country (2018-2029)
3.4.3 North America Nasal Spray Influenza Vaccine Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Nasal Spray Influenza Vaccine Market Facts & Figures by Country
3.5.1 Europe Nasal Spray Influenza Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Nasal Spray Influenza Vaccine Sales by Country (2018-2029)
3.5.3 Europe Nasal Spray Influenza Vaccine Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Nasal Spray Influenza Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific Nasal Spray Influenza Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Nasal Spray Influenza Vaccine Sales by Country (2018-2029)
3.6.3 Asia Pacific Nasal Spray Influenza Vaccine Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Nasal Spray Influenza Vaccine Market Facts & Figures by Country
3.7.1 Latin America Nasal Spray Influenza Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Nasal Spray Influenza Vaccine Sales by Country (2018-2029)
3.7.3 Latin America Nasal Spray Influenza Vaccine Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Nasal Spray Influenza Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Nasal Spray Influenza Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Nasal Spray Influenza Vaccine Sales by Country (2018-2029)
3.8.3 Middle East and Africa Nasal Spray Influenza Vaccine Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Nasal Spray Influenza Vaccine Sales by Type (2018-2029)
4.1.1 Global Nasal Spray Influenza Vaccine Sales by Type (2018-2024)
4.1.2 Global Nasal Spray Influenza Vaccine Sales by Type (2024-2029)
4.1.3 Global Nasal Spray Influenza Vaccine Sales Market Share by Type (2018-2029)
4.2 Global Nasal Spray Influenza Vaccine Revenue by Type (2018-2029)
4.2.1 Global Nasal Spray Influenza Vaccine Revenue by Type (2018-2024)
4.2.2 Global Nasal Spray Influenza Vaccine Revenue by Type (2024-2029)
4.2.3 Global Nasal Spray Influenza Vaccine Revenue Market Share by Type (2018-2029)
4.3 Global Nasal Spray Influenza Vaccine Price by Type (2018-2029)
5 Segment by Application
5.1 Global Nasal Spray Influenza Vaccine Sales by Application (2018-2029)
5.1.1 Global Nasal Spray Influenza Vaccine Sales by Application (2018-2024)
5.1.2 Global Nasal Spray Influenza Vaccine Sales by Application (2024-2029)
5.1.3 Global Nasal Spray Influenza Vaccine Sales Market Share by Application (2018-2029)
5.2 Global Nasal Spray Influenza Vaccine Revenue by Application (2018-2029)
5.2.1 Global Nasal Spray Influenza Vaccine Revenue by Application (2018-2024)
5.2.2 Global Nasal Spray Influenza Vaccine Revenue by Application (2024-2029)
5.2.3 Global Nasal Spray Influenza Vaccine Revenue Market Share by Application (2018-2029)
5.3 Global Nasal Spray Influenza Vaccine Price by Application (2018-2029)
6 Key Companies Profiled
6.1 AstraZeneca
6.1.1 AstraZeneca Corporation Information
6.1.2 AstraZeneca Description and Business Overview
6.1.3 AstraZeneca Nasal Spray Influenza Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.1.4 AstraZeneca Nasal Spray Influenza Vaccine Product Portfolio
6.1.5 AstraZeneca Recent Developments/Updates
6.2 Cipla
6.2.1 Cipla Corporation Information
6.2.2 Cipla Description and Business Overview
6.2.3 Cipla Nasal Spray Influenza Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.2.4 Cipla Nasal Spray Influenza Vaccine Product Portfolio
6.2.5 Cipla Recent Developments/Updates
6.3 BCHT
6.3.1 BCHT Corporation Information
6.3.2 BCHT Description and Business Overview
6.3.3 BCHT Nasal Spray Influenza Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.3.4 BCHT Nasal Spray Influenza Vaccine Product Portfolio
6.3.5 BCHT Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Nasal Spray Influenza Vaccine Industry Chain Analysis
7.2 Nasal Spray Influenza Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Nasal Spray Influenza Vaccine Production Mode & Process
7.4 Nasal Spray Influenza Vaccine Sales and Marketing
7.4.1 Nasal Spray Influenza Vaccine Sales Channels
7.4.2 Nasal Spray Influenza Vaccine Distributors
7.5 Nasal Spray Influenza Vaccine Customers
8 Nasal Spray Influenza Vaccine Market Dynamics
8.1 Nasal Spray Influenza Vaccine Industry Trends
8.2 Nasal Spray Influenza Vaccine Market Drivers
8.3 Nasal Spray Influenza Vaccine Market Challenges
8.4 Nasal Spray Influenza Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Nasal Spray Influenza Vaccine Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Nasal Spray Influenza Vaccine Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Nasal Spray Influenza Vaccine Market Competitive Situation by Manufacturers in 2022
Table 4. Global Nasal Spray Influenza Vaccine Sales (K Units) of Key Manufacturers (2018-2024)
Table 5. Global Nasal Spray Influenza Vaccine Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Nasal Spray Influenza Vaccine Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Nasal Spray Influenza Vaccine Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Nasal Spray Influenza Vaccine Average Price (US$/Unit) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Nasal Spray Influenza Vaccine, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Nasal Spray Influenza Vaccine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Nasal Spray Influenza Vaccine, Product Type & Application
Table 12. Global Key Manufacturers of Nasal Spray Influenza Vaccine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Nasal Spray Influenza Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nasal Spray Influenza Vaccine as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Nasal Spray Influenza Vaccine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Nasal Spray Influenza Vaccine Sales by Region (2018-2024) & (K Units)
Table 18. Global Nasal Spray Influenza Vaccine Sales Market Share by Region (2018-2024)
Table 19. Global Nasal Spray Influenza Vaccine Sales by Region (2024-2029) & (K Units)
Table 20. Global Nasal Spray Influenza Vaccine Sales Market Share by Region (2024-2029)
Table 21. Global Nasal Spray Influenza Vaccine Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Nasal Spray Influenza Vaccine Revenue Market Share by Region (2018-2024)
Table 23. Global Nasal Spray Influenza Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Nasal Spray Influenza Vaccine Revenue Market Share by Region (2024-2029)
Table 25. North America Nasal Spray Influenza Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Nasal Spray Influenza Vaccine Sales by Country (2018-2024) & (K Units)
Table 27. North America Nasal Spray Influenza Vaccine Sales by Country (2024-2029) & (K Units)
Table 28. North America Nasal Spray Influenza Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Nasal Spray Influenza Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Nasal Spray Influenza Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Nasal Spray Influenza Vaccine Sales by Country (2018-2024) & (K Units)
Table 32. Europe Nasal Spray Influenza Vaccine Sales by Country (2024-2029) & (K Units)
Table 33. Europe Nasal Spray Influenza Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Nasal Spray Influenza Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Nasal Spray Influenza Vaccine Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Nasal Spray Influenza Vaccine Sales by Region (2018-2024) & (K Units)
Table 37. Asia Pacific Nasal Spray Influenza Vaccine Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Nasal Spray Influenza Vaccine Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Nasal Spray Influenza Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Nasal Spray Influenza Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Nasal Spray Influenza Vaccine Sales by Country (2018-2024) & (K Units)
Table 42. Latin America Nasal Spray Influenza Vaccine Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Nasal Spray Influenza Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Nasal Spray Influenza Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Nasal Spray Influenza Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Nasal Spray Influenza Vaccine Sales by Country (2018-2024) & (K Units)
Table 47. Middle East & Africa Nasal Spray Influenza Vaccine Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Nasal Spray Influenza Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Nasal Spray Influenza Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Nasal Spray Influenza Vaccine Sales (K Units) by Type (2018-2024)
Table 51. Global Nasal Spray Influenza Vaccine Sales (K Units) by Type (2024-2029)
Table 52. Global Nasal Spray Influenza Vaccine Sales Market Share by Type (2018-2024)
Table 53. Global Nasal Spray Influenza Vaccine Sales Market Share by Type (2024-2029)
Table 54. Global Nasal Spray Influenza Vaccine Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Nasal Spray Influenza Vaccine Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Nasal Spray Influenza Vaccine Revenue Market Share by Type (2018-2024)
Table 57. Global Nasal Spray Influenza Vaccine Revenue Market Share by Type (2024-2029)
Table 58. Global Nasal Spray Influenza Vaccine Price (US$/Unit) by Type (2018-2024)
Table 59. Global Nasal Spray Influenza Vaccine Price (US$/Unit) by Type (2024-2029)
Table 60. Global Nasal Spray Influenza Vaccine Sales (K Units) by Application (2018-2024)
Table 61. Global Nasal Spray Influenza Vaccine Sales (K Units) by Application (2024-2029)
Table 62. Global Nasal Spray Influenza Vaccine Sales Market Share by Application (2018-2024)
Table 63. Global Nasal Spray Influenza Vaccine Sales Market Share by Application (2024-2029)
Table 64. Global Nasal Spray Influenza Vaccine Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Nasal Spray Influenza Vaccine Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Nasal Spray Influenza Vaccine Revenue Market Share by Application (2018-2024)
Table 67. Global Nasal Spray Influenza Vaccine Revenue Market Share by Application (2024-2029)
Table 68. Global Nasal Spray Influenza Vaccine Price (US$/Unit) by Application (2018-2024)
Table 69. Global Nasal Spray Influenza Vaccine Price (US$/Unit) by Application (2024-2029)
Table 70. AstraZeneca Corporation Information
Table 71. AstraZeneca Description and Business Overview
Table 72. AstraZeneca Nasal Spray Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 73. AstraZeneca Nasal Spray Influenza Vaccine Product
Table 74. AstraZeneca Recent Developments/Updates
Table 75. Cipla Corporation Information
Table 76. Cipla Description and Business Overview
Table 77. Cipla Nasal Spray Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 78. Cipla Nasal Spray Influenza Vaccine Product
Table 79. Cipla Recent Developments/Updates
Table 80. BCHT Corporation Information
Table 81. BCHT Description and Business Overview
Table 82. BCHT Nasal Spray Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 83. BCHT Nasal Spray Influenza Vaccine Product
Table 84. BCHT Recent Developments/Updates
Table 85. Key Raw Materials Lists
Table 86. Raw Materials Key Suppliers Lists
Table 87. Nasal Spray Influenza Vaccine Distributors List
Table 88. Nasal Spray Influenza Vaccine Customers List
Table 89. Nasal Spray Influenza Vaccine Market Trends
Table 90. Nasal Spray Influenza Vaccine Market Drivers
Table 91. Nasal Spray Influenza Vaccine Market Challenges
Table 92. Nasal Spray Influenza Vaccine Market Restraints
Table 93. Research Programs/Design for This Report
Table 94. Key Data Information from Secondary Sources
Table 95. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Nasal Spray Influenza Vaccine
Figure 2. Global Nasal Spray Influenza Vaccine Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Nasal Spray Influenza Vaccine Market Share by Type in 2022 & 2029
Figure 4. Inactive Product Picture
Figure 5. Live Product Picture
Figure 6. Global Nasal Spray Influenza Vaccine Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 7. Global Nasal Spray Influenza Vaccine Market Share by Application in 2022 & 2029
Figure 8. Child
Figure 9. Adult
Figure 10. Global Nasal Spray Influenza Vaccine Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 11. Global Nasal Spray Influenza Vaccine Market Size (2018-2029) & (US$ Million)
Figure 12. Global Nasal Spray Influenza Vaccine Sales (2018-2029) & (K Units)
Figure 13. Global Nasal Spray Influenza Vaccine Average Price (US$/Unit) & (2018-2029)
Figure 14. Nasal Spray Influenza Vaccine Report Years Considered
Figure 15. Nasal Spray Influenza Vaccine Sales Share by Manufacturers in 2022
Figure 16. Global Nasal Spray Influenza Vaccine Revenue Share by Manufacturers in 2022
Figure 17. The Global 5 and 10 Largest Nasal Spray Influenza Vaccine Players: Market Share by Revenue in 2022
Figure 18. Nasal Spray Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 19. Global Nasal Spray Influenza Vaccine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 20. North America Nasal Spray Influenza Vaccine Sales Market Share by Country (2018-2029)
Figure 21. North America Nasal Spray Influenza Vaccine Revenue Market Share by Country (2018-2029)
Figure 22. United States Nasal Spray Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 23. Canada Nasal Spray Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Europe Nasal Spray Influenza Vaccine Sales Market Share by Country (2018-2029)
Figure 25. Europe Nasal Spray Influenza Vaccine Revenue Market Share by Country (2018-2029)
Figure 26. Germany Nasal Spray Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. France Nasal Spray Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. U.K. Nasal Spray Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. Italy Nasal Spray Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Russia Nasal Spray Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Asia Pacific Nasal Spray Influenza Vaccine Sales Market Share by Region (2018-2029)
Figure 32. Asia Pacific Nasal Spray Influenza Vaccine Revenue Market Share by Region (2018-2029)
Figure 33. China Nasal Spray Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Japan Nasal Spray Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. South Korea Nasal Spray Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. India Nasal Spray Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Australia Nasal Spray Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. China Taiwan Nasal Spray Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Indonesia Nasal Spray Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Thailand Nasal Spray Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Malaysia Nasal Spray Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Latin America Nasal Spray Influenza Vaccine Sales Market Share by Country (2018-2029)
Figure 43. Latin America Nasal Spray Influenza Vaccine Revenue Market Share by Country (2018-2029)
Figure 44. Mexico Nasal Spray Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Brazil Nasal Spray Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Argentina Nasal Spray Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Middle East & Africa Nasal Spray Influenza Vaccine Sales Market Share by Country (2018-2029)
Figure 48. Middle East & Africa Nasal Spray Influenza Vaccine Revenue Market Share by Country (2018-2029)
Figure 49. Turkey Nasal Spray Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Saudi Arabia Nasal Spray Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. UAE Nasal Spray Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Global Sales Market Share of Nasal Spray Influenza Vaccine by Type (2018-2029)
Figure 53. Global Revenue Market Share of Nasal Spray Influenza Vaccine by Type (2018-2029)
Figure 54. Global Nasal Spray Influenza Vaccine Price (US$/Unit) by Type (2018-2029)
Figure 55. Global Sales Market Share of Nasal Spray Influenza Vaccine by Application (2018-2029)
Figure 56. Global Revenue Market Share of Nasal Spray Influenza Vaccine by Application (2018-2029)
Figure 57. Global Nasal Spray Influenza Vaccine Price (US$/Unit) by Application (2018-2029)
Figure 58. Nasal Spray Influenza Vaccine Value Chain
Figure 59. Nasal Spray Influenza Vaccine Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Distributors Profiles
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed